Related Experiment Videos

Screening for complement deficiencies in patients surviving from epidemic meningococcal disease

J M Rasmussen1, B Teisner, P Weihe

  • 1Institute of Medical Microbiology, Odense University, Denmark.

Journal of Clinical & Laboratory Immunology
|April 1, 1988
PubMed

Insights

Complement deficiencies are not a significant risk factor for meningococcal disease epidemics. A study found only one case of C3-deficiency linked to C3 nephritic factor (C3NeF) among survivors.

Area of Science:

  • Immunology
  • Infectious Diseases

Background:

  • Meningococcal disease outbreaks pose significant public health challenges.
  • The role of complement system deficiencies in disease susceptibility requires further investigation.

Purpose of the Study:

  • To investigate complement (C) system deficiencies in patients who survived meningococcal disease.
  • To determine if complement deficiencies are a risk factor during meningococcal disease epidemics.

Main Methods:

  • Screening of 132 patient sera for hemolytic complement function.
  • Immunochemical quantification of complement proteins in samples with reduced function.
  • Identification of C3-deficiency and C3 nephritic factor (C3NeF).

Main Results:

  • One patient identified with C3-deficiency (6% of normal) due to C3NeF.
  • Eight patients showed minor complement protein aberrations.
  • C3NeF did not cross-react with Neisseria meningitidis antigens.

Conclusions:

  • Complement deficiency is not a major risk factor during meningococcal disease epidemics.
  • C3NeF activity is not associated with cross-reactivity to specific Neisseria meningitidis strains.

Related Concept Videos